We will include 222 patients in the trial. 111 of the participants will receive an active Airsonett® treatment device and 111 will receive a placebo / inactivated device. During the trial participants and the trial team will not know which device each individual participant has.

[divider]
By on March 15, 2015   /    
[divider]